ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges
Some Enzo Biochem, Inc. (NYSE:ENZ) Shareholders Look For Exit As Shares Take 33% Pounding
Express News | Enzo Biochem Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q1 Revenue Results
Enzo Biochem Non-GAAP EPS of -$0.05, Revenue of $6.21M
Enzo Biochem Q1 Loss Declines
Enzo Biochem | 10-Q: Q1 2025 Earnings Report
Press Release: Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update
Enzo Biochem 1Q Loss $3.38M >ENZ
Enzo Biochem 1Q Rev $6.21M >ENZ
Top Stock Reports for Amgen, Eaton & Enzo Biochem
Enzo Biochem Appoints Jon Couchman to Board
We're Keeping An Eye On Enzo Biochem's (NYSE:ENZ) Cash Burn Rate
Enzo Biochem Full Year 2024 Earnings: US$0.19 Loss per Share (Vs US$0.51 Loss in FY 2023)
Enzo Biochem To Go Ex-Dividend On November 15th, 2024 With 0.1 USD Special Dividend Per Share
Enzo Biochem | 8-K: Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend
ENZ Stock Up Following FY24 Earnings Uptick, Gross Margin Expands
Enzo Biochem GAAP EPS of -$0.19, Revenue of $31.9M
Enzo Biochem 4Q Rev $7.5M >ENZ
Express News | Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend
Express News | Enzo Biochem, Inc. FY EPS USD 0.41
No Data